Wei Ding
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
- Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 9
-
- Cancer-related molecular mechanisms research 9
- Co-authors
- Xuezhong Xu (13 shared papers)Yulin Tan (11 shared papers)Yibo Wang (7 shared papers)An-Yang Wei (7 shared papers)Xiao‐Xin Shi (9 shared papers)Lei Jin (2 shared papers)Jianguo Du (2 shared papers)Xia Lü (5 shared papers)
- Journals
- Medicine (7 papers)Tetrahedron Asymmetry (4 papers)PLoS ONE (3 papers)Journal of Oncology (3 papers)Chinese Journal of Chemistry (3 papers)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Wei Ding
84 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 84
- Hepatology 104
- Cancer Research 139
- Oncology 160
- Psychiatry and Mental health 93
- Rheumatology 64
Countries citing papers authored by Wei Ding
This map shows the geographic impact of Wei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ding more than expected).
Fields of papers citing papers by Wei Ding
This network shows the impact of papers produced by Wei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ding. The network helps show where Wei Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 89 | |
| 2 | 2019 | 88 | |
| 3 | 2018 | 82 | |
| 4 | 2019 | 65 | |
| 5 | 2019 | 38 | |
| 6 | 2021 | 36 | |
| 7 | 2017 | 32 | |
| 8 | 2019 | 30 | |
| 9 | 2020 | 30 | |
| 10 | 2003 | 28 | |
| 11 | 2020 | 26 | |
| 12 | 2017 | 25 | |
| 13 | 2019 | 25 | |
| 14 | 2020 | 25 | |
| 15 | 2020 | 25 | |
| 16 | 2012 | 23 | |
| 17 | 2014 | 23 | |
| 18 | 2021 | 23 | |
| 19 | 2021 | 22 | |
| 20 | 2018 | 20 |
About Wei Ding
Wei Ding is a scholar working on Hepatology, Cancer Research, Oncology, Organic Chemistry and Pulmonary and Respiratory Medicine, having authored 90 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer-related molecular mechanisms research (9 papers), Sexual function and dysfunction studies (6 papers), Asymmetric Synthesis and Catalysis (5 papers), Advanced Synthetic Organic Chemistry (5 papers), Organic Chemistry Synthesis Methods (4 papers), Liquid Crystal Research Advancements (4 papers) and Photochromic and Fluorescence Chemistry (4 papers). The work is most often cited by research in Hepatology (104 citations), Cancer Research (139 citations), Oncology (160 citations), Psychiatry and Mental health (93 citations) and Rheumatology (64 citations). Wei Ding has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Xuezhong Xu, Yulin Tan, Yibo Wang, An-Yang Wei, Xiao‐Xin Shi, Lei Jin, Jianguo Du, Xia Lü, Feng-Zhi Chen and David Warburton. Their work appears in journals such as Medicine, Tetrahedron Asymmetry, PLoS ONE, Journal of Oncology and Chinese Journal of Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.